XML 42 R31.htm IDEA: XBRL DOCUMENT v3.21.1

Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2021

IPO One [Member]

Schedule of Net Proceeds from Offering

The Company received net proceeds from this offering as follows:

Description		Amount
Net proceeds received:
Proceeds from the sale of 2,800,000 shares of Common Stock at $3.095 per share		$	8,666,000
Proceeds from the sale of pre-funded warrants to purchase 7,200,000 shares of Common Stock at $3.085 per share			22,212,000
Less: Placement agent fees and other expenses of the offering			(1,937,000	)
Net proceeds of the offering		$	28,941,000

IPO One [Member] | Warrant Derivative Liability [Member]

Schedule of Net Proceeds from Offering

Accordingly, the Company allocated a portion of the net proceeds of this offering to warrant derivative liabilities based on their estimated fair value as follows (See Notes 4 and 10) :

Description		Amount
Warrant derivative liabilities		$	21,922,158
Pre-funded warrant derivative liabilities			378,615
Total allocation of the net proceeds of the offering to warrant derivative liabilities		$	22,300,773

IPO Two [Member]

Schedule of Net Proceeds from Offering

The Company received net proceeds from this offering as follows:

Description		Amount
Net proceeds received:
Proceeds from the sale of 3,250,000 shares of Common Stock at $2.80 per share		$	9,100,000
Proceeds from the sale of pre-funded warrants to purchase 11,050,000 shares of Common Stock at $2.79 per share			30,829,500
Less: Placement agent fees and other expenses of the offering			(2,482,400	)
Net proceeds of the offering		$	37,447,100

IPO Two [Member] | Warrant Derivative Liability [Member]

Schedule of Net Proceeds from Offering

Accordingly, the Company allocated a portion of the net proceeds of this offering to warrant derivative liabilities based on their estimated fair value as follows (See Notes 4 and 10):

Description		Amount
Warrant derivative liabilities		$	27,476,352
Pre-funded warrant derivative liabilities			1,438,934
Total allocation of the net proceeds of the offering to warrant derivative liabilities		$	28,915,286

X

- Definition

Tabular disclosure of sales of stock or previously unissued stock made by subsidiary or equity method investee to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=DGLY_IPOOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=DGLY_WarrantLiabilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=DGLY_IPOTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: